其 他 安 全 警 示
|
| |
| Australia: Safety advisory: Counterfeit Alprazolam 2mg and Kalma 2 tablets (English only) |
| |
The Therapeutic Goods Administration (TGA) announces that testing of a number of products labelled Alprazolam 2mg and Kalma 2 has found that:
- The Alprazolam 2mg product is an attempted counterfeit of a genuine product in the international marketplace. Whilst this is a genuine product in the United States of America, it is not supplied legally in Australia.
- The Kalma 2 product is an attempted counterfeit of a genuine Australian product and is being illegally supplied.
- Counterfeit Alprazolam 2mg tablets and Kalma 2 tablets may contain a range of undeclared substances in different combinations and dosages. Undeclared substances that may be present include etizolam, cyproheptadine, promethazine, flubromazepam, amantadine, etc.
The counterfeit tablets present with the following features, which differ from the genuine product:
- The number under the barcode on the side of the label does not match the NDC number displayed on the front of the package at the top.
- The counterfeit Alprazolam 2mg product does not include a QR code with the Lot number, Serial Number and Expiry beside it (located near the barcode on the label of the genuine product).
- The counterfeit Kalma 2 product does not include the Manufacturers logo (Mylan).
Please refer to the following website in TGA for details:
http://www.tga.gov.au/alert/counterfeit-alprazolam-2mg-and-kalma-2-tablets
In Hong Kong, the above products are not registered pharmaceutical products.
Ends/Tuesday, Jun 30, 2020
Issued at HKT 16:00
|
| |
